In-vivo thrombus in-situ forming device

By designing an in-situ thrombosis formation device in vivo, using technologies such as sliding columns and rotating components, the problem of thrombin solution and blood being mixed in advance is solved, the effective formation and diversification of thrombus in a specific position is achieved, and the quality of thrombus formation is improved .

CN118924483AActive Publication Date: 2024-11-12JIANGSU MEIFENGLI MEDICAL TECH CO LTD +1
View PDF 9 Cites 0 Cited by

Patent Information

Application Number
CN202411320599.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-23
Publication Date
2024-11-12
Estimated Expiration
2044-09-23

AI Technical Summary

Technical Problem

When a thrombus is formed in the body, the thrombin solution is easy to mix with the blood in advance, resulting in the failure of the thrombus to form at a specific location, especially when the target blood vessel is large in diameter, it is difficult to form and transport the thrombus in vitro.

Method used

A device for in vivo thrombosis formation is designed, including a catheter head, a mirror-distributed flexible ring, annular array of fluid injection holes, sliding columns and flow holes. The fluid injection holes are sealed in advance through the sliding column, and the thrombin solution is injected to promote flow. The well is connected to the injection hole to prevent the thrombin solution from mixing with the blood in advance, and adjust the injection direction and amount of the thrombin solution by rotating the assembly and adapting the assembly.

Benefits of technology

It effectively avoids the advance mixing of thrombin solution and blood, ensures that the thrombus is formed in a specific position, and increases the type and quality of the thrombus formation, reducing the risk of adhesion between the thrombus and the device.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118924483A_ABST
    Figure CN118924483A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of thrombus prosthesis formation, in particular to an in-vivo thrombus in-situ formation device. Comprising a catheter head, the catheter head is fixedly connected with flexible rings distributed in a mirror image mode, the catheter head is provided with liquid injection holes in an annular array, the liquid injection holes in the annular array are located between the flexible rings distributed in the mirror image mode, the catheter head is slidably and rotatably connected with a sliding column, the catheter head is fixedly connected with a fixing ring, and the fixing ring is fixedly connected with the catheter head. The sliding column is provided with a circulation hole, the catheter head is fixedly connected with a fixed communication cylinder, the sliding column and the fixed communication cylinder are matched to form a first closed cavity, and the catheter head is fixedly connected with a liquid injection pipe. The liquid injection hole is blocked in advance through the sliding column, then the circulation hole communicates with the liquid injection hole through injection pushing force of a thrombin solution, the thrombin solution enters the blood vessel, and the situation that when blood in the blood vessel moves along the blood vessel, the thrombin solution leaks and is mixed with the blood in advance, and consequently thrombus is not formed in a specific position is avoided.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of thrombus prosthesis formation, and in particular to a device for in-situ thrombus formation in vivo. Background Art

[0002] Thrombotic diseases have become a major type of disease that affects people's life and health, including myocardial infarction, cerebral infarction, peripheral blood, arterial embolism, pulmonary embolism, etc. At present, there are many innovative treatment devices for thrombotic diseases in China, such as thrombus aspiration catheters, thrombectomy stents, etc. These related devices need to conduct preclinical animal studies before entering the clinic to verify the feasibility, safety and effectiveness of the device in treating thrombotic diseases in animals. Therefore, the prerequisite is to be able to create a suitable thromboembolic model on animals.

[0003] There are two main technical lines for establishing this type of model. The first is to make a thrombus in vitro and input it into the body through certain equipment. The second technical route is not to make a thrombus in vitro, but to form a thrombus in situ in the target blood vessel in the body. When the diameter of the target blood vessel to be obstructed is large, this thrombus cannot be formed in vitro, and it will be very difficult to transport. Therefore, we will use relevant tools to form a thrombus in vivo. This process requires the use of a microcatheter to move along the blood vessel to the target blood vessel, and then use two microballoons to block both ends of the target blood vessel, and then inject thrombin solution into the blood between the two microballoons, so that the blood in the target blood vessel and the thrombin solution form a thrombus. However, when the microcatheter moves along the blood vessel, the thrombin solution waiting to be injected can easily enter the blood vessel during the movement, causing the thrombin solution to exchange and mix with the blood in advance, resulting in some thrombi not forming in specific locations. Summary of the invention

[0004] In order to overcome the shortcomings mentioned in the above background technology, the present invention provides a device for in situ thrombus formation in vivo.

[0005] The technical solution is as follows: An in-vivo thrombus in-situ formation device comprises a catheter head, the catheter head is fixedly connected with a flexible ring distributed in a mirror image, the catheter head is provided with an annular array of injection holes, the injection holes of the annular array are located between the flexible rings distributed in a mirror image, and the distances between the injection holes and the flexible rings distributed in a mirror image are consistent, a sliding column is slidably and rotatably connected inside the catheter head, a fixed ring is fixedly connected inside the catheter head, a first elastic element is arranged between the sliding column and the fixed ring, the sliding column is provided with a flow hole, the injection holes of the annular array are all communicated and cooperated with the flow hole, a fixed connecting tube is fixedly connected inside the catheter head, the sliding column is sealingly and slidingly connected with the fixed connecting tube, the sliding column cooperates with the fixed connecting tube to form a first closed cavity, the flow hole on the sliding column is communicated with the first closed cavity, an injection tube is fixedly connected inside the catheter head, the first closed cavity is communicated with the injection tube, and an injection component for expanding the flexible ring distributed in a mirror image is arranged in the catheter head.

[0006] Preferably, a side of the fixing ring close to the sliding column is fixedly connected with a limiting block in mirror distribution, and the limiting blocks in mirror distribution are all in limiting cooperation with the sliding column.

[0007] Preferably, the distance between the limit block and the sliding column is a, the distance between the central axis of the flow hole and the central axis of the adjacent injection hole is b, a=b, which is used to make the flow hole accurately connected with the adjacent injection hole.

[0008] Preferably, the flexible ring is recessed inside the catheter head to reduce the contact between the flexible ring and the thrombus.

[0009] Preferably, the gas injection assembly includes a first gas injection pipe, which is fixedly connected to the interior of the catheter head; the catheter head, the flexible ring close to the liquid injection pipe, the sliding column and the fixed connecting cylinder cooperate to form a second closed cavity; the catheter head, the flexible ring away from the liquid injection pipe and the sliding column cooperate to form a third closed cavity; the sliding column is provided with a mirror-distributed gas injection channel, which connects the second closed cavity with the third closed cavity.

[0010] Preferably, the mirror-distributed gas injection channels and the flow holes are staggered in distribution.

[0011] Preferably, it also includes a rotating component for rotating the sliding column, the rotating component is arranged inside the fixed connecting cylinder, the rotating component includes a sliding shaft, the sliding shaft is splined to the inside of the sliding column, the sliding shaft is fixedly connected with a clamping shaft in the fixed connecting cylinder, the inner wall of the fixed connecting cylinder is provided with a rotating groove, the clamping shaft is slidably connected to the rotating groove, a driving component for pushing the sliding shaft to move is provided in the fixed connecting cylinder, and an adaptation component for maintaining the volume of the first closed cavity is provided on the sliding column.

[0012] Preferably, the driving assembly includes a fixed cylinder, which is fixedly connected to the interior of the fixed connecting cylinder, and a first piston shaft is slidably connected to the interior of the fixed cylinder, and the first piston shaft is fixedly connected to the sliding shaft, and a second elastic element is arranged between the fixed cylinder and the first piston shaft, and the first piston shaft cooperates with the fixed cylinder to form a fourth closed cavity, and the catheter head is fixedly connected to a second gas injection pipe, which passes through the fixed connecting cylinder and is connected to the fourth closed cavity.

[0013] Preferably, the adaption assembly comprises an adjusting cylinder, the adjusting cylinder is fixedly connected to the sliding column, the sliding shaft is fixedly connected to a second piston shaft, and the adjusting cylinder is sealingly and slidingly connected to the second piston shaft.

[0014] Preferably, evenly distributed stirring shafts are fixedly connected inside the sliding column to stir the solution in the sliding column.

[0015] The beneficial effects of the present invention are: 1. The injection hole is blocked in advance by a sliding column, and then the flow hole is connected with the injection hole by the injection driving force of the thrombin solution, so that the thrombin solution enters the blood vessel, thereby preventing the thrombin solution from leaking and mixing with the blood in advance when the blood in the blood vessel moves along the blood vessel, resulting in thrombus not being formed at a specific position.

[0016] 2. The sliding shaft drives the sliding column to rotate synchronously, and the sliding column drives the flow holes on it to rotate synchronously. The flow holes rotate and dock with the other injection holes in sequence, changing the direction of the thrombin solution entering the blood vessel, so that the thrombus is formed at different positions in the target blood vessel, increasing the types of thrombus formation.

[0017] 3. The second piston shaft slides along the regulating cylinder to make up for the reduced volume of the closed cavity formed by the sliding column and the fixed connecting cylinder, so that the thrombin solution in the closed cavity is replenished into the regulating cylinder to avoid the increase of the content of thrombin solution entering the blood vessel. BRIEF DESCRIPTION OF THE DRAWINGS

[0018] Figure 1 It is a schematic diagram of the three-dimensional structure of the present invention; Figure 2It is a schematic cross-sectional view of the three-dimensional structure of the catheter head of the present invention; Figure 3 It is a schematic cross-sectional view of the three-dimensional structure of the catheter head and the flexible ring of the present invention; Figure 4 It is a schematic diagram of the three-dimensional structure of the gas injection channel of the present invention; Figure 5 It is a schematic cross-sectional view of the three-dimensional structure of the fixed connecting tube of the present invention; Figure 6 It is a schematic cross-sectional view of the three-dimensional structure of the fixing cylinder of the present invention; Figure 7 It is a schematic cross-sectional view of the three-dimensional structure of the adjusting cylinder and the sliding column of the present invention.

[0019] Explanation of the reference numerals: 1-catheter head, 2-flexible ring, 3-liquid injection hole, 4-sliding column, 5-fixed ring, 6-first elastic element, 7-circulation hole, 8-fixed connecting cylinder, 9-liquid injection tube, 10-limiting block, 201-first gas injection tube, 202-gas injection channel, 301-sliding shaft, 302-clamping shaft, 303-rotating slide groove, 304-fixed cylinder, 305-first piston shaft, 306-second elastic element, 307-second gas injection tube, 401-adjusting cylinder, 402-second piston shaft, 403-stirring shaft. DETAILED DESCRIPTION

[0020] The following descriptions are merely preferred embodiments of the present invention and are not intended to limit the protection scope of the present invention.

[0021] When the microcatheter moves along the blood vessel, the thrombin solution waiting to be injected can easily enter the blood vessel during the movement, causing the thrombin solution to exchange and mix with the blood in advance, resulting in the thrombus not being formed at a specific location.

[0022] Example 1: A device for in situ thrombosis formation in vivo, such as Figure 1-Figure 4As shown, it includes a catheter head 1, which is fixedly connected to two flexible rings 2 distributed in mirror image. The flexible ring 2 can be expanded and stretched into a sphere, and then contact with the target blood vessel and block the target blood vessel. The flexible ring 2 is concave inside the catheter head 1 in an unexpanded state, and is used to reduce the contact between the flexible ring 2 and the thrombus when the device is withdrawn after thrombus formation, and avoid the synchronous movement of the thrombus formed by adhesion of the flexible ring 2. The catheter head 1 is provided with an annular array of injection holes 3, and the annular array of injection holes 3 is located between the flexible rings 2 distributed in mirror image, and the distance between the injection hole 3 and the flexible ring 2 distributed in mirror image is consistent, so that the injection position of thrombin is The catheter head 1 is arranged between two flexible rings 2, and a sliding column 4 is connected to the inside of the catheter head 1 for sliding and rotation. A fixing ring 5 is fixedly connected inside the catheter head 1. A first elastic element 6 is arranged between the sliding column 4 and the fixing ring 5. The first elastic element 6 is a spring. The first elastic element 6 is used to drive the sliding column 4 to reset. The sliding column 4 is provided with a flow hole 7. The injection holes 3 in the annular array are all connected and matched with the flow hole 7. A fixed connecting tube 8 is fixedly connected inside the catheter head 1. The sliding column 4 is sealed and slidably connected with the fixed connecting tube 8. The sliding column 4 cooperates with the fixed connecting tube 8 to form a first closed cavity. The flow hole 7 on the sliding column 4 is connected to the first closed cavity. The interior of the catheter head 1 is fixedly connected with an injection tube 9, the first closed cavity is communicated with the injection tube 9, and the thrombin solution is injected into the first closed cavity through the injection tube 9, so that the thrombin solution pushes the sliding column 4 to slide along the fixed connecting tube 8, thereby driving the flow hole 7 on the sliding column 4 to communicate with the adjacent injection hole 3, so that the thrombin solution enters the blood vessel, and the lower side of the fixed ring 5 is fixedly connected with two limit blocks 10 distributed in a mirror image, and the two limit blocks 10 distributed in a mirror image are both limited with the sliding column 4, so that the two limit blocks 10 distributed in a mirror image hinder the sliding of the sliding column 4, and the distance between the limit block 10 and the sliding column 4 is a, and the flow The distance between the central axis of the through hole 7 and the central axis of the adjacent injection hole 3 is b, a=b, which is used to make the circulation hole 7 accurately connected with the adjacent injection hole 3, so as to prevent the thrombin solution from pushing the sliding column 4 to slide too far and sealing the injection hole 3 again. The catheter head 1 is provided with an injection component for expanding the mirror-distributed flexible ring 2. The injection hole 3 is sealed in advance through the sliding column 4, and then the circulation hole 7 is connected with the injection hole 3 through the injection driving force of the thrombin solution, so that the thrombin solution enters the blood vessel, so as to prevent the thrombin solution from leaking and mixing with the blood in advance when the blood in the blood vessel moves along the blood vessel, resulting in the thrombus not being formed at a specific position.

[0023] like Figure 2-Figure 4As shown, the gas injection assembly includes a first gas injection tube 201, which is connected to an external gas injection device. The catheter head 1, the flexible ring 2 below, the sliding column 4 and the fixed connecting tube 8 cooperate to form a second closed cavity. The catheter head 1, the flexible ring 2 above, and the sliding column 4 cooperate to form a third closed cavity. Two mirror-distributed gas injection channels 202 are arranged on the sliding column 4. The two mirror-distributed gas injection channels 202 are staggered with the flow hole 7. The two mirror-distributed gas injection channels 202 connect the second closed cavity and the third closed cavity, so as to expand the two flexible rings 2 and block the blood vessels.

[0024] When the staff needs to form a thrombus in the animal's blood vessel, the staff places the device in the blood vessel through vascular intervention, and then the staff controls the device to move into the blood vessel until the catheter head 1 moves to the position where a thrombus needs to be formed. The staff stops moving the device, and then the staff turns on the external gas injection device, and the gas injection device injects gas into the first gas injection pipe 201. The gas enters the second closed cavity along the first gas injection pipe 201, and then the gas in the second closed cavity enters the third closed cavity along the two mirror-distributed injection flow channels 202. As the gas gradually enters, the gas content in the second closed cavity and the third closed cavity gradually increases, causing the two mirror-distributed flexible rings 2 to begin to expand, until the flexible ring 2 expands to contact and fit the inner wall of the blood vessel, so that the two mirror-distributed flexible rings 2 block the blood vessel, and then the external gas injection device is closed.

[0025] After the blood vessel is blocked, the staff starts to inject thrombin solution into the injection tube 9. At this time, the thrombin solution enters the fixed connecting tube 8 along the injection tube 9, and then enters the sliding column 4 along the fixed connecting tube 8, and this continues until the thrombin solution gradually fills the first closed cavity. When the first closed cavity is filled, the thrombin solution continues to be injected into the first closed cavity. As the thrombin solution enters the first closed cavity, the thrombin solution pushes the sliding column 4 to slide along the fixed connecting tube 8, and the first elastic element 6 is compressed at the same time, until the sliding column 4 slides to contact the two limit blocks 10 distributed in a mirror image, so that the two limit blocks 10 limit the sliding column 4 to prevent sliding. The moving column 4 continues to slide along the fixed connecting tube 8, and the sliding column 4 drives the flow hole 7 thereon to connect with the adjacent injection hole 3. At this time, the thrombin solution in the first closed cavity enters the blood vessel along the flow hole 7 and the injection hole 3 connected thereto, so that the thrombin solution is mixed with the blood in the blood vessel, and the blood in the blood vessel begins to coagulate to form a thrombus, and this is done until the thrombus formation is completed. The injection hole 3 is blocked in advance by the sliding column 4, and then the flow hole 7 is connected with the injection hole 3 by the injection driving force of the thrombin solution, so that the thrombin solution enters the blood vessel, so as to avoid the leakage of the thrombin solution and the mixing with the blood in advance when the blood in the blood vessel moves along the blood vessel, resulting in the thrombus not being formed at a specific position.

[0026] After a thrombus is formed, the staff stops injecting thrombin solution into the injection tube 9. At this time, the first elastic element 6 is reset and pushes the sliding column 4 to reset synchronously. The sliding column 4 causes the flow hole 7 thereon to be misaligned with the injection hole 3. At this time, the thrombin solution in the first closed cavity cannot enter the blood vessel. Then the external gas injection device is turned on to extract the gas in the second closed cavity and the third closed cavity. At this time, the gas in the second closed cavity and the third closed cavity flows back to the outside along the first gas injection tube 201, causing the two flexible rings 2 to shrink to the initial state. Then the staff takes the device out of the blood vessel. At this time, the thrombus preparation in the blood vessel is completed. When the thrombus in the blood vessel needs to be prepared again, repeat the above steps.

[0027] Embodiment 2: Based on embodiment 1, Figure 5 and Figure 6 As shown, it also includes a rotating component for rotating the sliding column 4, the rotating component is arranged inside the fixed connecting cylinder 8, the rotating component includes a sliding shaft 301, the sliding shaft 301 is splined to the inside of the sliding column 4, and is initially located inside the fixed connecting cylinder 8, the sliding shaft 301 is fixedly connected with a clamping shaft 302 in the fixed connecting cylinder 8, the inner wall of the fixed connecting cylinder 8 is provided with a rotating slide groove 303, the rotating slide groove 303 is a spiral groove, the clamping shaft 302 is slidably connected with the rotating slide groove 303, the sliding shaft 301 drives the clamping shaft 302 thereon to slide along the slide groove 303, so that the sliding column 4 drives the flow hole 7 to rotate, and is connected with the injection holes 3 of the annular array in sequence, changing the direction of the thrombin solution entering the blood vessel, so that the thrombus is formed at different positions in the target blood vessel, and increasing the type of thrombus formation, a driving component for driving the sliding shaft 301 to move is arranged in the fixed connecting cylinder 8, and an adaptation component for maintaining the volume of the first closed cavity is arranged on the sliding column 4.

[0028] like Figure 5 and Figure 6 As shown, the driving assembly includes a fixed cylinder 304, which is fixedly connected to the inside of the fixed connecting cylinder 8, and the inside of the fixed cylinder 304 is slidably connected with the first piston shaft 305. A second elastic element 306 is arranged between the fixed cylinder 304 and the first piston shaft 305. The second elastic element 306 is a spring. The second elastic element 306 is used to drive the first piston shaft 305 to reset. The first piston shaft 305 cooperates with the fixed cylinder 304 to form a fourth closed cavity. The catheter head 1 is fixedly connected with a second gas injection pipe 307, and the second gas injection pipe 307 is connected to the external gas injection device. The second gas injection pipe 307 runs through the fixed connecting cylinder 8, and the second gas injection pipe 307 is connected to the fourth closed cavity, which is used to inject gas into the fourth closed cavity, thereby pushing the first piston shaft 305 to drive the sliding shaft 301 to move.

[0029] like Figure 3 , Figure 5 and Figure 7As shown, the adaptation component includes an adjusting cylinder 401, which is fixedly connected to the sliding column 4, and the sliding shaft 301 is fixedly connected to the second piston shaft 402. The adjusting cylinder 401 and the second piston shaft 402 are sealed and slidably connected, and the sliding shaft 301 drives the second piston shaft 402 to slide synchronously to make up for the reduced volume of the first closed cavity, so that the thrombin solution in the first closed cavity is replenished into the adjusting cylinder 401 to avoid the increase of the content of the thrombin solution entering the blood vessel, and the sliding column 4 is fixedly connected with uniformly distributed stirring shafts 403. The sliding column 4 rotates and drives the uniformly distributed stirring shafts 403 therein to stir the thrombin solution, so that the thrombin in the thrombin solution is evenly distributed.

[0030] After the blood vessel is blocked by the two flexible rings 2, the external gas injection device is turned on, and the gas injection device begins to inject gas into the second gas injection pipe 307. At this time, the gas enters the fourth closed cavity along the second gas injection pipe 307. After the gas enters the fourth closed cavity, the gas pushes the first piston shaft 305 to slide along the fixed cylinder 304. At the same time, the second elastic element 306 is compressed, and the first piston shaft 305 drives the sliding shaft 301 to slide along the sliding column 4. The first piston shaft 305 drives the card shaft 302 thereon to move synchronously. The card shaft 302 slides along the rotating slide groove 303. The rotating slide groove 303 drives the sliding shaft 301 to rotate by squeezing the card shaft 302. The sliding shaft 301 drives The movable sliding column 4 rotates synchronously, and the sliding column 4 drives the flow hole 7 thereon to rotate synchronously, so that the flow hole 7 rotates to the bottom of the target injection hole 3, and then starts to inject thrombin solution into the first closed cavity, so that the flow hole 7 rotates and docks with the target injection hole 3, changes the direction of the thrombin solution entering the blood vessel, and makes the thrombus form at different positions in the target blood vessel, increasing the type of thrombus formation, and so on until the thrombin solution is injected to the required amount, and then opens the external gas injection device to extract the gas in the fourth closed cavity, at this time the second elastic element 306 is reset, and drives the first piston shaft 305 to reset, when it is necessary to change the injection direction of thrombin, repeat the above steps.

[0031] When the first piston shaft 305 drives the sliding shaft 301 to slide along the sliding column 4, the volume of the first closed cavity is gradually reduced. At this time, the solution in the first closed cavity will be further injected into the blood vessel, resulting in an excessive amount of thrombin solution injected. At this time, the sliding shaft 301 drives the second piston shaft 402 to move synchronously, and the second piston shaft 402 slides along the regulating cylinder 401. The reduced volume of the first closed cavity allows the thrombin solution in the first closed cavity to be replenished into the regulating cylinder 401, thereby avoiding an increase in the content of the thrombin solution entering the blood vessel. At the same time, when the sliding column 4 rotates, it drives the stirring shaft 403 evenly distributed inside it to rotate, and stirs the thrombin solution inside the sliding column 4, thereby improving the uniformity of the thrombin solution and the quality of subsequent thrombus.

[0032] The above descriptions are merely embodiments of the present invention and are not intended to limit the patent scope of the present invention. Any equivalent structure or equivalent process transformation made using the contents of the present invention specification, or directly or indirectly applied in other related technical fields, are also included in the patent protection scope of the present invention.

Claims

1. A device for in situ thrombosis formation in vivo, characterized in that: The invention comprises a catheter head (1), wherein the catheter head (1) is fixedly connected to a flexible ring (2) distributed in a mirror image, the catheter head (1) is provided with a ring array of injection holes (3), the injection holes (3) in the ring array are located between the flexible rings (2) distributed in a mirror image, and the distances between the injection holes (3) and the flexible rings (2) distributed in a mirror image are consistent, a sliding column (4) is slidably and rotatably connected inside the catheter head (1), a fixing ring (5) is fixedly connected inside the catheter head (1), a first elastic element (6) is provided between the sliding column (4) and the fixing ring (5), and the sliding column (4) is provided with a flow hole ( 7), the injection holes (3) of the annular array are all connected and matched with the circulation holes (7), a fixed connecting tube (8) is fixedly connected inside the catheter head (1), the sliding column (4) is sealingly and slidingly connected with the fixed connecting tube (8), the sliding column (4) and the fixed connecting tube (8) cooperate to form a first closed cavity, the circulation hole (7) on the sliding column (4) is connected with the first closed cavity, an injection tube (9) is fixedly connected inside the catheter head (1), the first closed cavity is connected with the injection tube (9), and an injection component for expanding the mirror-distributed flexible ring (2) is provided inside the catheter head (1).

2. The in vivo thrombus in situ formation device according to claim 1, characterized in that: A side of the fixed ring (5) close to the sliding column (4) is fixedly connected with a limit block (10) distributed in a mirror image, and the limit blocks (10) distributed in a mirror image are all in position-limiting cooperation with the sliding column (4).

3. The in vivo thrombus in situ formation device according to claim 2, characterized in that: The distance between the limit block (10) and the sliding column (4) is a, and the distance between the central axis of the circulation hole (7) and the central axis of the adjacent injection hole (3) is b, where a=b, so that the circulation hole (7) is accurately connected to the adjacent injection hole (3).

4. The in vivo thrombus in situ formation device according to claim 3, characterized in that: The flexible ring (2) is recessed inside the catheter head (1) to reduce the contact between the flexible ring (2) and the thrombus.

5. The in vivo thrombus in situ formation device according to claim 1, characterized in that: The gas injection assembly comprises a first gas injection pipe (201), the first gas injection pipe (201) being fixedly connected to the interior of the catheter head (1); the catheter head (1), the flexible ring (2) close to the liquid injection pipe (9), the sliding column (4) and the fixed connecting tube (8) cooperate to form a second closed cavity; the catheter head (1), the flexible ring (2) away from the liquid injection pipe (9) and the sliding column (4) cooperate to form a third closed cavity; the sliding column (4) is provided with a mirror-distributed gas injection channel (202), the mirror-distributed gas injection channel (202) connecting the second closed cavity and the third closed cavity.

6. The in vivo thrombus in situ formation device according to claim 1, characterized in that: The mirror-image-distributed gas injection channels (202) and the flow holes (7) are distributed in a staggered manner.

7. The in vivo thrombus in situ formation device according to claim 5, characterized in that: The invention also comprises a rotating assembly for rotating the sliding column (4), the rotating assembly being arranged inside the fixed connecting cylinder (8), the rotating assembly comprising a sliding shaft (301), the sliding shaft (301) being spline-connected inside the sliding column (4), the sliding shaft (301) being fixedly connected with a clamping shaft (302) inside the fixed connecting cylinder (8), a rotating groove (303) being arranged on the inner wall of the fixed connecting cylinder (8), the clamping shaft (302) being slidably connected with the rotating groove (303), a driving assembly for driving the sliding shaft (301) to move being arranged inside the fixed connecting cylinder (8), and an adapting assembly for maintaining the volume of the first closed cavity being arranged on the sliding column (4).

8. The in vivo thrombus formation in situ device according to claim 6, characterized in that: The drive assembly comprises a fixed cylinder (304), the fixed cylinder (304) being fixedly connected to the interior of the fixed connecting cylinder (8), a first piston shaft (305) being slidably connected to the interior of the fixed cylinder (304), the first piston shaft (305) being fixedly connected to the sliding shaft (301), a second elastic element (306) being arranged between the fixed cylinder (304) and the first piston shaft (305), the first piston shaft (305) and the fixed cylinder (304) cooperating to form a fourth closed cavity, the catheter head (1) being fixedly connected to a second gas injection pipe (307), the second gas injection pipe (307) passing through the fixed connecting cylinder (8), and the second gas injection pipe (307) being connected to the fourth closed cavity.

9. The in vivo thrombus in situ formation device according to claim 8, characterized in that: The adaptability component comprises an adjustment cylinder (401), the adjustment cylinder (401) is fixedly connected to the sliding column (4), the sliding shaft (301) is fixedly connected to a second piston shaft (402), and the adjustment cylinder (401) is sealingly and slidingly connected to the second piston shaft (402).

10. The in vivo thrombus in situ formation device according to claim 9, characterized in that: The sliding column (4) is fixedly connected to the inside thereof with evenly distributed stirring shafts (403) for stirring the solution in the sliding column (4).

Citation Information

Patent Citations

  • Improvements in urinary catheters

    CN104010689B

  • Double-balloon injection catheter instrument for blood vessel thrombolysis

    CN112914677A

  • Pseudo-aneurysm sealer

    CN113940724A

  • Deep vein thrombosis modeling device and method

    CN114748204A

  • Blood vessel perforation plugging device and use method thereof

    CN117084739A